Gonadotropin releasing hormone agonist treatment before hysteroscopic metroplasty

P. Vercellini, G. Ragni, A. Colombo, S. Oldani, S. Panazza, P. G. Crosignani

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We performed hysteroscopic incision of uterine septum in 22 women with repeated abortion. The patients underwent surgery during the proliferative phase (group 1, 12 subjects) or 4 weeks after a subcutaneous goserelin (3.6 mg) depot injection (group 2, 10 subjects) to evaluate surgical and anatomic results in hypo-oestrogenic women. Metroplasty was performed with microscissors. After the operation the surgeon classified the intra-uterine operating conditions as unfavourable, usual or optimal. In group 1 the mean operating time was 19 min with a standard deviation (SD) of 5 min, compared with 13 min with a SD of 6 in group 2 (P = 0.02). The mean distension medium deficit was 620 ml with a SD of 175 in group 1 vs. 340 ml with a SD of 213 in group 2 (P = 0.003). One group 1 woman with partial uterine septum had a fundal perforation which was managed conservatively. The intra-uterine operating conditions were judged to be usual or optimal in 50% of cases in group 1 vs. 90% in group 2 (P = 0.04). At follow-up ultrasonography and hysteroscopy performed 2 months after surgery, a residual fundal notch ≥ 1 cm deep was detected and corrected in three patients in each group. In our series of hysteroscopic metroplasties, a single gonadotropin releasing hormone agonist depot injection improved the operating conditions, reducing the operating time and the distension fluid deficit. The anatomic results were comparable in the two study groups.

Original languageEnglish
Pages (from-to)153-157
Number of pages5
JournalGynaecological Endoscopy
Volume2
Issue number3
Publication statusPublished - 1993

Fingerprint

Gonadotropin-Releasing Hormone
Goserelin
Hysteroscopy
Injections
Ultrasonography
Therapeutics
Surgeons

Keywords

  • abortion
  • gonadotropin releasing hormone agonist
  • hysteroscopy
  • uterine malformations

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Obstetrics and Gynaecology

Cite this

Vercellini, P., Ragni, G., Colombo, A., Oldani, S., Panazza, S., & Crosignani, P. G. (1993). Gonadotropin releasing hormone agonist treatment before hysteroscopic metroplasty. Gynaecological Endoscopy, 2(3), 153-157.

Gonadotropin releasing hormone agonist treatment before hysteroscopic metroplasty. / Vercellini, P.; Ragni, G.; Colombo, A.; Oldani, S.; Panazza, S.; Crosignani, P. G.

In: Gynaecological Endoscopy, Vol. 2, No. 3, 1993, p. 153-157.

Research output: Contribution to journalArticle

Vercellini, P, Ragni, G, Colombo, A, Oldani, S, Panazza, S & Crosignani, PG 1993, 'Gonadotropin releasing hormone agonist treatment before hysteroscopic metroplasty', Gynaecological Endoscopy, vol. 2, no. 3, pp. 153-157.
Vercellini P, Ragni G, Colombo A, Oldani S, Panazza S, Crosignani PG. Gonadotropin releasing hormone agonist treatment before hysteroscopic metroplasty. Gynaecological Endoscopy. 1993;2(3):153-157.
Vercellini, P. ; Ragni, G. ; Colombo, A. ; Oldani, S. ; Panazza, S. ; Crosignani, P. G. / Gonadotropin releasing hormone agonist treatment before hysteroscopic metroplasty. In: Gynaecological Endoscopy. 1993 ; Vol. 2, No. 3. pp. 153-157.
@article{c95c2d33eb104e2bba128ba8691fa7f3,
title = "Gonadotropin releasing hormone agonist treatment before hysteroscopic metroplasty",
abstract = "We performed hysteroscopic incision of uterine septum in 22 women with repeated abortion. The patients underwent surgery during the proliferative phase (group 1, 12 subjects) or 4 weeks after a subcutaneous goserelin (3.6 mg) depot injection (group 2, 10 subjects) to evaluate surgical and anatomic results in hypo-oestrogenic women. Metroplasty was performed with microscissors. After the operation the surgeon classified the intra-uterine operating conditions as unfavourable, usual or optimal. In group 1 the mean operating time was 19 min with a standard deviation (SD) of 5 min, compared with 13 min with a SD of 6 in group 2 (P = 0.02). The mean distension medium deficit was 620 ml with a SD of 175 in group 1 vs. 340 ml with a SD of 213 in group 2 (P = 0.003). One group 1 woman with partial uterine septum had a fundal perforation which was managed conservatively. The intra-uterine operating conditions were judged to be usual or optimal in 50{\%} of cases in group 1 vs. 90{\%} in group 2 (P = 0.04). At follow-up ultrasonography and hysteroscopy performed 2 months after surgery, a residual fundal notch ≥ 1 cm deep was detected and corrected in three patients in each group. In our series of hysteroscopic metroplasties, a single gonadotropin releasing hormone agonist depot injection improved the operating conditions, reducing the operating time and the distension fluid deficit. The anatomic results were comparable in the two study groups.",
keywords = "abortion, gonadotropin releasing hormone agonist, hysteroscopy, uterine malformations",
author = "P. Vercellini and G. Ragni and A. Colombo and S. Oldani and S. Panazza and Crosignani, {P. G.}",
year = "1993",
language = "English",
volume = "2",
pages = "153--157",
journal = "Gynaecological Endoscopy",
issn = "0962-1091",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Gonadotropin releasing hormone agonist treatment before hysteroscopic metroplasty

AU - Vercellini, P.

AU - Ragni, G.

AU - Colombo, A.

AU - Oldani, S.

AU - Panazza, S.

AU - Crosignani, P. G.

PY - 1993

Y1 - 1993

N2 - We performed hysteroscopic incision of uterine septum in 22 women with repeated abortion. The patients underwent surgery during the proliferative phase (group 1, 12 subjects) or 4 weeks after a subcutaneous goserelin (3.6 mg) depot injection (group 2, 10 subjects) to evaluate surgical and anatomic results in hypo-oestrogenic women. Metroplasty was performed with microscissors. After the operation the surgeon classified the intra-uterine operating conditions as unfavourable, usual or optimal. In group 1 the mean operating time was 19 min with a standard deviation (SD) of 5 min, compared with 13 min with a SD of 6 in group 2 (P = 0.02). The mean distension medium deficit was 620 ml with a SD of 175 in group 1 vs. 340 ml with a SD of 213 in group 2 (P = 0.003). One group 1 woman with partial uterine septum had a fundal perforation which was managed conservatively. The intra-uterine operating conditions were judged to be usual or optimal in 50% of cases in group 1 vs. 90% in group 2 (P = 0.04). At follow-up ultrasonography and hysteroscopy performed 2 months after surgery, a residual fundal notch ≥ 1 cm deep was detected and corrected in three patients in each group. In our series of hysteroscopic metroplasties, a single gonadotropin releasing hormone agonist depot injection improved the operating conditions, reducing the operating time and the distension fluid deficit. The anatomic results were comparable in the two study groups.

AB - We performed hysteroscopic incision of uterine septum in 22 women with repeated abortion. The patients underwent surgery during the proliferative phase (group 1, 12 subjects) or 4 weeks after a subcutaneous goserelin (3.6 mg) depot injection (group 2, 10 subjects) to evaluate surgical and anatomic results in hypo-oestrogenic women. Metroplasty was performed with microscissors. After the operation the surgeon classified the intra-uterine operating conditions as unfavourable, usual or optimal. In group 1 the mean operating time was 19 min with a standard deviation (SD) of 5 min, compared with 13 min with a SD of 6 in group 2 (P = 0.02). The mean distension medium deficit was 620 ml with a SD of 175 in group 1 vs. 340 ml with a SD of 213 in group 2 (P = 0.003). One group 1 woman with partial uterine septum had a fundal perforation which was managed conservatively. The intra-uterine operating conditions were judged to be usual or optimal in 50% of cases in group 1 vs. 90% in group 2 (P = 0.04). At follow-up ultrasonography and hysteroscopy performed 2 months after surgery, a residual fundal notch ≥ 1 cm deep was detected and corrected in three patients in each group. In our series of hysteroscopic metroplasties, a single gonadotropin releasing hormone agonist depot injection improved the operating conditions, reducing the operating time and the distension fluid deficit. The anatomic results were comparable in the two study groups.

KW - abortion

KW - gonadotropin releasing hormone agonist

KW - hysteroscopy

KW - uterine malformations

UR - http://www.scopus.com/inward/record.url?scp=0027364826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027364826&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0027364826

VL - 2

SP - 153

EP - 157

JO - Gynaecological Endoscopy

JF - Gynaecological Endoscopy

SN - 0962-1091

IS - 3

ER -